Global barriers to decision makers for prioritizing interventions for obesity.

ABSTRACT: The treatment of obesity remains underprioritized. New pharmacologic options for the treatment of obesity have shown effectiveness and safety but are not widely reimbursed. Despite the unmet need and the existence of effective prevention and treatment strategies, substantial barriers exist to effectively address obesity as a disease. The purpose of this scoping review was to investigate the barriers for decision makers in prioritizing interventions for obesity and to seek out interconnection between barriers to prevention and treatment. A scoping review was conducted using a systematic search of both scientific databases and Health Technology Assessment (HTA) databases. Studies that addressed barriers to reimbursement or prioritization of obesity treatment and prevention were included. A t

SUBMITTER: Ehlers LH 

PROVIDER: S-EPMC11805708 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature